Skip to main content
×
Home
    • Aa
    • Aa

Intake and status of folate and related B-vitamins: considerations and challenges in achieving optimal status

  • Helene McNulty (a1) and John M. Scott (a2)
Abstract

Folate and the metabolically related B-vitamins, vitamin B12 and riboflavin, have attracted much scientific and public health interest in recent years. Apart from a well established role in preventing neural tube defects (NTDs), evidence is emerging to support other potential roles for folate and/or related B-vitamins in protecting against cardiovascular disease (especially stroke), certain cancers, cognitive impairment and osteoporosis. However, typical folate intakes are sub-optimal, in that although adequate in preventing clinical folate deficiency (i.e. megaloblastic anaemia) in most people, they are generally insufficient to achieve a folate status associated with the lowest risk of NTDs. Natural food folates have a limited ability to enhance folate status as a result of their poor stability under typical cooking conditions and incomplete bioavailability when compared with the synthetic vitamin, folic acid (as found in supplements and fortified foods). Current folate recommendations to prevent NTDs (based primarily on folic acid supplementation) have been found to be ineffective in several European countries. In contrast, in North America and Chile, the policy of mandatory folic acid-fortification has proven itself in terms of lowering the prevalence of NTD, but remains controversial because of concerns regarding potential risks of chronic exposure to high-dose folic acid. In the case of vitamin B12, the achievement of an optimal status is particularly difficult for many older people because of the common problem of food-bound B12 malabsorption. Finally, there is evidence that riboflavin status is generally low in the UK population, and particularly so in younger women; this warrants further investigation.

  • View HTML
    • Send article to Kindle

      To send this article to your Kindle, first ensure no-reply@cambridge.org is added to your Approved Personal Document E-mail List under your Personal Document Settings on the Manage Your Content and Devices page of your Amazon account. Then enter the ‘name’ part of your Kindle email address below. Find out more about sending to your Kindle.

      Note you can select to send to either the @free.kindle.com or @kindle.com variations. ‘@free.kindle.com’ emails are free but can only be sent to your device when it is connected to wi-fi. ‘@kindle.com’ emails can be delivered even when you are not connected to wi-fi, but note that service fees apply.

      Find out more about the Kindle Personal Document Service.

      Intake and status of folate and related B-vitamins: considerations and challenges in achieving optimal status
      Available formats
      ×
      Send article to Dropbox

      To send this article to your Dropbox account, please select one or more formats and confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your Dropbox account. Find out more about sending content to Dropbox.

      Intake and status of folate and related B-vitamins: considerations and challenges in achieving optimal status
      Available formats
      ×
      Send article to Google Drive

      To send this article to your Google Drive account, please select one or more formats and confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your Google Drive account. Find out more about sending content to Google Drive.

      Intake and status of folate and related B-vitamins: considerations and challenges in achieving optimal status
      Available formats
      ×
Copyright
Corresponding author
*Corresponding author: Professor Helene McNulty, fax +44 028 70323023, email h.mcnulty@ulster.ac.uk
References
Hide All
1McNulty H & Pentieva K (2004) Folate bioavailability. Proc Nutr Soc 63, 529536.
2Institute of Medicine, Panel on Folate, Other B Vitamins, and Choline (1998) Dietary Reference Intake; Thiamine, Riboflavin, Niacin, Vitamin B6, Folate, Vitamin B12, Pantothenic Acid, Biotin, and Choline. Washington, DC: National Academy Press.
3Sauberlich HE, Kretsch MJ, Skala JH, Johnson HL & Taylor RC (1987) Folate requirement and metabolism in nonpregnant women. Am J Clin Nutr 46, 10161028.
4Pfeiffer CM, Rogers LM, Bailey LB & Gregory JF (1997) Absorption of folate from fortified cereal-grain products and of supplemental folate consumed with or without food determined by using a dual-label stable-isotope protocol. Am J Clin Nutr 66, 13881397.
5Hannon-Fletcher MP, Armstrong NC, Scott JM, et al. (2004) Determination of the bioavailability of food folates in a controlled intervention study. Am J Clin Nutr 80, 911918.
6Winkels RM, Brouwer IA, Siebelink E, Katan MB & Verhoef P (2007) Bioavailability of food folates is 80 % of that of folic acid. Am J Clin Nutr 85, 465473.
7Miller JW, Garrod MG, Rockwood AL, Kushnir MM, Allen LH, Haan MN & Green R (2006) Measurement of total vitamin B12 and holotranscobalamin, singly and in combination, in screening for metabolic vitamin B12 deficiency. Clin Chem 52, 278285.
8Ueland PM, Eilertsen I, Quadros EV, Rothenberg SP, Fedosov SN, Sundrehagen E & Orning L (2002) Direct assay for cobalamin bound to transcobalamin (holo-transcobalamin) in serum. Clin Chem 48, 526532.
9Morkbak AL, Heimdal RM, Emmens K, Molloy A, Hvas AM, Schneede J, Clarke R, Scott JM, Ueland PM & Nexo E (2005) Evaluation of the technical performance of novel holotranscobalamin (holoTC) assays in a multicenter European demonstration project. Clin Chem Lab Med 43, 10581064.
10Hvas AM & Nexo E (2005) Holotranscobalamin – a first choice assay for diagnosing early vitamin B deficiency? J Intern Med 257, 289298.
11Clarke R, Refsum H, Birks J, et al. (2003) Screening for vitamin B-12 and folate deficiency in older persons. Am J Clin Nutr 77, 12411247.
12Wolters M, Strohle A & Hahn A (2004) Cobalamin: a critical vitamin in the elderly. Prev Med 39, 12561266.
13Henderson L, Irving K, Gregory J, Bates CJ, Prentice A, Perks J, Swan G & Farron M (2003) The National Diet and Nutrition Survey: Adults Aged 19 to 64 years. Volume 3: Vitamin and Mineral Intake and Urinary Analytes. London: The Stationery Office.
14Carmel R (1997) Cobalamin, the stomach, and aging. Am J Clin Nutr 66, 750759.
15Dickinson CJ (1995) Does folic acid harm people with vitamin B12 deficiency? Q J Med 88, 357364.
16Mills JL, Von Kohorn I, Conley MR, Zeller JA, Cox C, Williamson RE & Dufour DR (2003) Low vitamin B12 concentrations in patients without anemia: the effect of folic acid fortification of grain. Am J Clin Nutr 77, 14741477.
17Liu S, West R, Randell E, et al. (2004) A comprehensive evaluation of food fortification with folic acid for the primary prevention of neural tube defects. BMC Pregnancy Childbirth 4, 2029.
18Morris MS, Jacques PF, Rosenberg IH & Selhub J (2007) Folate and vitamin B12 status in relation to anemia, macrocytosis, and cognitive impairment in older Americans in the age of folic acid fortification. Am J Clin Nutr 85, 193200.
19Gibson RS (2005) Assessment of the status of thiamin, riboflavin and niacin. In Principles of Nutritional Assessment, 2nd ed. pp. 545574, New York: Oxford University Press.
20Powers HJ, Bates CJ, Prentice AM, Lamb WH, Jepson M & Bowman H (1983) The relative effectiveness of iron and iron with riboflavin in correcting a microcytic anaemia in men and children in rural Gambia. Hum Nutr Clin Nutr 37C, 413425.
21Department of Health (1991) Dietary Reference Values for Food, Energy and Nutrients for the United Kingdom. London: The Stationery Office.
22Gregory J, Foster K, Tyler H & Wiseman M (1990) The Dietary and Nutritional Survey of British Adults. London: The Stationery Office.
23Ruston D, Hoare J, Henderson L, Gregory J, Bates CJ, Prentice A, Birch M, Swan G & Farron M (2004) The National Diet and Nutrition Survey: Adults Aged 19 to 64 years. Volume 4: Nutritional Status (Anthropometry and Blood Analytes), Blood Pressure and Physical Activity. London: The Stationery Office.
24Hustad S, McKinley M, McNulty H, Schneede J, Strain JJ, Scott JM & Ueland PM (2002) Riboflavin, flavin mononucleotide, and flavin adenine dinucleotide in human plasma and erythryocytes at baseline and after low-dose riboflavin supplementation. Clin Chem 48, 15711577.
25Eichholzer M, Tonz O & Zimmermann R (2006) Folic acid: a public-health challenge. Lancet 367, 13521361.
26Botto LD, Lisi A, Robert-Gnansia E, et al. (2005) International retrospective cohort study of neural tube defects in relation to folic acid recommendations: are the recommendations working? BMJ 330, 571576.
27Pfeiffer CM, Caudill SP, Gunter EW, Osterloh J & Sampson EJ (2005) Biochemical indicators of B vitamin status in the US population after folic acid fortification: results from the National Health and Nutrition Examination Survey 1999–2000. Am J Clin Nutr 82, 442450.
28Honein MA, Paulozzi LJ, Mathews TJ, Erickson JD & Wong L-YC (2001) Impact of folic acid fortification of the US food supply on the occurrence of neural tube defects. JAMA 285, 29812986.
29De Wals P, Tairou F, Van Allen MI, et al. (2007) Reduction in neural-tube defects after folic acid fortification in Canada. N Engl J Med 357, 135142.
30Homocysteine Studies Collaboration (2002) Homocysteine and risk of ischemic heart disease and stroke. JAMA 288, 20152022.
31Wald DS, Law M & Morris JK (2002) Homocysteine and cardiovascular disease: evidence on causality from a meta-analysis. BMJ 325, 12021208.
32Frosst P, Blom HJ, Milos R, et al. (1995) A candidate genetic risk factor for vascular disease: a common mutation in methylenetetrahydrofolate reductase. Nat Genet 10, 111113.
33Wilcken B, Bamforth F, Li Z, et al. (2003) Geographical and ethnic variation of the 677C>T allele of 5,10 methylenetetrahydrofolate reductase (MTHFR): findings from over 7000 newborns from 16 areas world wide. J Med Genet 40, 619625.
34Klerk M, Verhoef P, Clarke R, Blom HJ, Kok FJ & Schouten EG (2003) MTHFR 677C>T polymorphism and risk of coronary heart disease: a meta-analysis. JAMA 288, 20232031.
35Lewis SJ, Ebrahim S & Davey Smith G (2005) Meta-analysis of MTHFR 677C → T polymorphism and coronary heart disease: does totality of evidence support causal role for homocysteine and preventive potential of folate. BMJ 331, 10531056.
36Yang Q, Botto LD, Erickson JD, Berry RJ, Sambell C, Johansen H & Friedman JM (2006) Improvement in stroke mortality in Canada and the United States, 1990 to 2002. Circulation 113, 13351343.
37Wang X, Qin X, Demirtas H, Li J, Mao G, Huo Y, Sun N, Liu L & Xu X (2007) Efficacy of folic acid supplementation in stroke prevention: a meta-analysis. Lancet 369, 18761882.
38Giovannucci E (2002) Epidemiologic studies of folate and colorectal neoplasia: a review. J Nutr 132, Suppl., 2350S2355S.
39Ericson U, et al. (2007) High folate intake is associated with lower breast cancer incidence in postmenopausal women in the Malmo Diet and Cancer cohort. Am J Clin Nutr 86, 434443.
40Cole BF, Baron JA, Sandler RS, et al. (2007) Folic acid for the prevention of colorectal adenomas: a randomized clinical trial. JAMA 297, 23512359.
41McMahon JA, Green TJ, Skeaff CM, Knight RG, Mann JI & Williams SM (2006) A controlled trial of homocysteine lowering and cognitive performance. N Engl J Med 354, 27642772.
42Durga J, van Boxtel MP, Schouten EG, Kok FJ, Jolles J, Katan MB & Verhoef P (2007) Effect of 3-year folic acid supplementation on cognitive function in older adults in the FACIT trial: a randomised, double blind, controlled trial. Lancet 369, 208216.
43Sato Y, Honda Y, Iwamoto J, Kanoko T & Satoh K (2005) Effect of folate and mecobalamin on hip fractures in patients with stroke: a randomized controlled trial. JAMA 293, 10821088.
44Homocysteine Lowering Trialists' Collaboration (1998) Lowering blood homocysteine with folic acid based supplements: meta-analysis of randomized trials. BMJ 316, 894898.
45Eussen SJPM, de Groot LCPGM, Clarke R, et al. (2005) Oral cyanocobalamin supplementation in older people with vitamin B12 deficiency. A dose finding trial. Arch Intern Med 165, 11671172.
46McKinley MC, McNulty H, McPartlin J, et al. (2001) Low-dose vitamin B6 effectively lowers fasting plasma homocysteine in healthy elderly persons who are folate and riboflavin replete. Am J Clin Nutr 73, 759764.
47McNulty H, Dowey LC, Strain JJ, Dunne A, Ward M, Molloy AM, McAnena LB, Hughes JP, Hannon-Fletcher M & Scott JM (2006) Riboflavin lowers homocysteine in individuals homozygous for the MTHFR 677C → T polymorphism. Circulation 113, 7480.
48Homocysteine Lowering Trialists' Collaboration (2005) Dose-dependant effects of folic acid on blood concentrations of homocysteine: a meta-analysis of the randomized trials. Am J Clin Nutr 82, 806812.
49Quinlivan EP, McPartlin J, McNulty H, Ward M, Strain JJ, Weir DG & Scott JM (2002) Importance of both folic acid and vitamin B-12 in reduction of risk of vascular disease. Lancet 359, 227228.
50Liaugaudas G, Jacques PF, Selhub J, Rosenberg IH & Boston AG (2001) Renal insufficiency, vitamin B-12 status, and population attributable risk for mild hyperhomocysteinemia among coronary artery disease patients in the era of folic acid-fortified cereal grain flour. Arterioscler Thromb Vasc Biol 21, 849851.
51Molloy AM, Daly S, Mills JL, Kirke PN, Whitehead AS, Ramsbottom D, Conley MR, Weir DG & Scott JM (1997) Thermolabile variant of 5,10-methylenetetrahydrofolate reductase associated with low red-cell folates: implications for folate intake recommendations. Lancet 349, 15911593.
52Jacques PF, Bostom AG, Williams RR, Ellison RC, Eckfeldt JH, Rosenberg IH, Selhub J & Rozen R (1996) Relation between folate status, a common mutation in methylenetetrahydrofolate reductase, and plasma homocysteine concentrations. Circulation 93, 79.
53Yamada K, Chen Z, Rozen R & Matthews RG (2001) Effects of common polymorphisms on the properties of recombinant human methylenetetrahydrofolate reductase. Proc Natl Acad Sci U S A 98, 1485314858.
54Hoey L, McNulty H, Askin N, Dunne A, Ward M, Pentieva K, Strain JJ, Molloy AM, Flynn C & Scott JM (2007) Impact of a voluntary food fortification policy on folate, related B-vitamin status and homocysteine in healthy adults. Am J Clin Nutr 86, 14051413.
Recommend this journal

Email your librarian or administrator to recommend adding this journal to your organisation's collection.

British Journal of Nutrition
  • ISSN: 0007-1145
  • EISSN: 1475-2662
  • URL: /core/journals/british-journal-of-nutrition
Please enter your name
Please enter a valid email address
Who would you like to send this to? *
×

Keywords:

Metrics

Altmetric attention score

Full text views

Total number of HTML views: 25
Total number of PDF views: 254 *
Loading metrics...

Abstract views

Total abstract views: 413 *
Loading metrics...

* Views captured on Cambridge Core between September 2016 - 24th October 2017. This data will be updated every 24 hours.